Cost-effectiveness analysis of gestational diabetes mellitus screening in France

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 103, Issue 2, 2002, Pages 122-129

  Poncet, Bénédicte ^a   Touzet, Sandrine ^a   Rocher, Laure ^b   Berland, Michel ^c   Orgiazzi, Jacques ^b   Colin, Cyrille ^a  

^a UMR 5823 CNRS   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Cost effectiveness of gestational diabetes screening; Decision analysis model

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRANCE; HIGH RISK POPULATION; HUMAN; LITERATURE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PERINATAL MORTALITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SCREENING; WORLD HEALTH ORGANIZATION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; GLUCOSE TOLERANCE TEST; INFANT MORTALITY; MACROSOMIA; MASS SCREENING; NEWBORN; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; RISK FACTOR;

COST-BENEFIT ANALYSIS; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; FRANCE; GLUCOSE TOLERANCE TEST; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037054714     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00042-8     Document Type: Article

References (55)

1. Summary and Recommendations of the Fourth International Workshop Conference on Gestational Diabetes Mellitus. The Organizing Committee
2. Screening of high-risk and general populations for gestational diabetes. Clinical application and cost analysis
3. Pregnancy outcomes in women without gestational diabetes mellitus related to the maternal glucose level. Is there a continuum of risk?
4. Difference in prevalence of gestational diabetes and perinatal outcome in an innercity multiethnic London population
5. Criteria for screening tests for gestational diabetes
6. Neonatal morbidities in gestational diabetes mellitus
7. Does gestational diabetes represent an obstetrical risk factor?
8. American Diabetes Association's Fourth International Workshop Conference on Gestational Diabetes Mellitus: Summary and Discussion. Therapeutic interventions
9. Screening for gestational diabetes: variation in guidelines
10. Gestational diabetes mellitus; resource utilization and costs of diagnosis and treatment
11. Economic impact of management strategies in gestational diabetes
12. Screening for gestational diabetes: an analysis of health benefits and costs
13. Strategic options for antenatal screening for syphilis in the United Kingdom: a cost-effectiveness analysis
14. Long-term prospective evaluation of offspring of diabetic mothers
15. Diabetes mellitus after GDM
16. Gestational diabetes and perinatal mortality rate
17. Screening criteria for high-risk gestational diabetic patients
18. Evaluation of the 3h oral glucose tolerance test in detection of significant hyperglycemia and hypoglycemia in pregnancy
19. Management and outcome of pregnancy in diabetes mellitus, classes B to R
20. Clinical experience with a screening program for gestational diabetes
21. Screening for gestational diabetes. Optimum timing and criteria for retesting
22. Screening of high-risk and general populations for gestational diabetes. Clinical application and cost analysis
23. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy. Long-term effects on obesity and glucose tolerance in the offspring
24. Gestational diabetes mellitus. Is further improvement necessary?
25. Gestational diabetes. Incidence, maternal characteristics, and perinatal outcome
26. Should the 50 g, 1 h plasma glucose screening test for gestational diabetes be administered in the fasting or fed state?
27. Relation of glucose tolerance to complications of pregnancy in non-diabetic women
28. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy
29. Maternal age and screening for gestational diabetes: a population-based study
30. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy
31. Gestational diabetes
32. New criteria for interpretation of the 75 g oral glucose tolerance test in pregnancy
33. Obstetric complications with GDM. Effects of maternal weight
34. Gestational diabetes mellitus. A survey of perinatal complications in the 1980s
35. Glucose tolerance test periodicity as a descriptor of glucose tolerance abnormality
36. Screening for gestational diabetes mellitus based on blood glucose 2 h value after a 75 g oral glucose load
37. Class A1 gestational diabetes: a meaningful diagnosis?
38. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity
39. Hypertension and pre-eclampsia in women with gestational glucose intolerance
40. Emotional adjustment to diagnosis and intensified treatment of gestational diabetes
41. The outcome of pregnancy following untreated impaired glucose tolerance
42. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto TriHospital gestational diabetes project
43. Mass screening of gestational diabetes using O'Sullivan's test in a hospital consultation. Experience in Rennes
44. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study
45. Selective screening for gestational diabetes mellitus. The Toronto Trihospital gestational diabetes project investigators
46. Gestational diabetes: an example of a rural region. The DIAGEST Group
47. The 75 g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes